News by region

  • Mediplus announces release of new sizes of POPY product range

    Mediplus has announced the release of new sizes of the POPY Mediplus has announced the release of new sizes of the POPY (Pelvic Organ Prolapse pessary) product range. The company is introducing five additional sizes to complement its existing products, offering a more precise fit and enhanced treatment options for women suffering from pelvic organ [...]

  • The Future Health, Leeds 2025: Industry leaders focus on collaboration to turn intent into real-world impact

    Taking stock of the UK's health tech landscape  On the evening of Thursday 8 May, over 150 leaders from across the healthcare industry came together for the latest event organised by The Future Health. The event, made possible by main sponsor Leeds-based digital transformation consultancy, Aire Logic, started with a lively panel debate chaired by former [...]

  • Shifting the conversation on in Primary Care

    By Daniel Park, CEO, InTouchNow, on moving beyond traditional automated telephony to intelligent conversation We're all badly conditioned by our banks to think that anything automated on the telephone is unintelligent.  For years, we've endured those frustrating automated telephone response systems – pressing keys, our voices not being recognised, getting stuck in loops and ultimately [...]

  • Discover investment opportunities & innovation at International Healthcare Week in Hong Kong

    The 4th International Healthcare Week (IHW), driven by the Hong Kong Trade Development Council (HKTDC), will run from 26 May to 15 June 2025 in Hong Kong, helping to promote innovation, investment and exchange by fully utilising Hong Kong’s strategic role as an innovation and investment hub for Asia’s healthcare industry. The two flagship events [...]

  • Health tech leaders respond to ICB model blueprint

    We’ve gathered responses from leaders at a range of health tech suppliers to understand more about what the changes to Integrated Care Boards (ICBs) could mean for the future of connected care. NHS England’s recently published ICB model blueprint will see Integrated Care Boards (ICB) transition from a mixed operational-commissioning model to becoming strategic commissioners [...]

  • MedTech companies Paxman and Dignitana announce merger

    Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new chapter of working together to advance side effect management for cancer patients around the world. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB [...]

  • Advancing neurostimulation: The impact of smaller batteries on implanted devices

    By John Tinson of Ilika Technologies Neurostimulation technology is a rapidly evolving field of medicine which has the potential to transform management of chronic pain, neurological disorders and psychiatric conditions. Implanted neurostimulation devices, such as spinal cord stimulators, deep brain stimulators and Vagus nerve stimulators work by delivering targeted electrical impulses to specific neural structures. [...]

  • The need for a risk-based approach to AI and machine learning in healthcare

    In this article, Tina Joros, JD, chair, and Stephen Speicher, MD, vice chair of the EHR Association AI Task Force explore the importance of a risk-based approach to AI and machine learning in healthcare. The regulatory landscape for artificial intelligence (AI) and machine learning (ML) continues to evolve. As the United States awaits the release [...]

  • Dxcover breaks new ground in search for higher brain cancer survival rates

    New research shows a clear association between brain tumour size and mortality, with earlier diagnosis linked to improved survival outcomes. The findings suggest that detecting brain cancer just one month earlier could reduce annual mortality risk by 18–28 per cent. Clinical-stage diagnostics company Dxcover Limited analysed records from 1,196 patients to evaluate how tumour size [...]

  • From crisis to resilience: how clinical trials can absorb future trade shocks through AI and blockchain

    By Martin Sandhu, healthtech founder & technology consultant The last global crisis changed clinical trials forever. When COVID-19 closed physical sites and restricted movement, the industry had no choice but to evolve. Decentralised clinical trials (DCTs)—once an emerging trend—became a necessity. The shift wasn’t seamless or universal. Smaller firms struggled with infrastructure, and many trials [...]